PHOTO
Dubai-UAE: Dubai Silicon Oasis Authority (DSOA), the regulatory body of Dubai Silicon Oasis (DSO), an integrated free zone technology park, today signed an agreement with Arabian Ethicals, a leading distributor for the import, storage, and distribution of life-sciences brands, to house the company’s regional headquarters and National Distribution Center at the high-tech park.
Dr Juma Al Matrooshi, Deputy CEO of DSOA, and Dr. Stephan Stauffer, General Manager of Arabian Ethicals, co-signed the agreement in the presence of senior officials from both parties, officially welcoming the company to DSO.
Operating from eight light industrial units, spanning a total of 2,880 square meters, Arabian Ethicals will utilize its move to further expand its presence in the MENA region. Currently, Arabian Ethicals imports more than 50 brands from various multinational pharmaceutical, consumer, and animal health manufacturers, and distributes them in the UAE.
Running for more than four decades in the UAE, the move to the brand-new premises will support short- and mid-term plans to consolidate operations and future expansion plans, including tapping into other GCC markets. The company also aims to forge more partnerships with companies that offer innovative products in niche areas – such as oncology, immunology, rare diseases, and others, and make them available to the patients in the UAE and across the GCC.
Welcoming the homegrown healthcare distributor, Dr Al Matrooshi said: “We are delighted to welcome Arabian Ethicals to DSO’s growing business community, a base of operations for businesses that operate across a diverse range of industries. The integrated technology park provides several offerings for business partners, and the flexibility to adjust as per their requirements. Arabian Ethicals has grown immensely over the past 40 years, and we look forward to supporting them in their next phase of expansion.”
He added: “Welcoming Arabian Ethicals’ follows a series of healthcare-focused ventures by Dubai Silicon Oasis Authority, including the recent opening of Fakeeh University Hospital. We are confident Arabian Ethicals will have the opportunity to leverage DSO’s unique mix of healthcare business partners.”
For his part, Dr. Stephan Stauffer said: “My team and I are passionate about healthcare and the opportunities we have to make our world a better and healthier place. Dubai Silicon Oasis is the ideal place for our brand-new regional headquarters and National Distribution Center, given its strategic location in the heart of Dubai, coupled with state-of-the-art infrastructure and easy access to key distribution routes. Dubai Silicon Oasis Authority also retains a passionate team that will enable us to realize our vision.”
Founded in 1977, Arabian Ethicals has grown to become the seventh largest pharmaceutical distribution company in the UAE with annual revenue exceeding AED300 million in 2020. A diverse workforce of more than 100 employees from more than 15 nationalities, speaking over 20 different languages, sets the customer-focused company apart.
The Light Industrial Units at DSO include an operational warehouse area and a double story office area. The area is in proximity to DSO’s entry and exit points, facilitating transport of goods, and the units feature a structural, mechanical, and electrical designed ceiling, and complete fiber optic networking infrastructure. The LIUs are all equipped with an electronic sounder, complete fibre optic networking, as well as CCTV, 24-hour security and fire alarm system. Using eco-friendly and high-quality materials, the units also meet green building specifications.
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
